{
  "id": 7287117,
  "title": "Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.",
  "url": "https://urgent.news/2026/09/14/novartis-just-shook-up-a-multibillion-dollar-drug-race-what-it-means",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-14T08:44:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/09/14/novartis-just-shook-up-a-multibillion-dollar-drug/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lilly may be impacted by Novartis' pelacarsen flop -- but not by much.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.",
        "url": "https://urgent.news/2026/09/14/novartis-just-shook-up-a-multibillion-dollar-drug-race-what-it-means-7288041",
        "published": "2026-09-14T09:04:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}